The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...

Rates of chronic liver disease during pregnancy are rising partly due to MASLD and the downward trend of chronic viral hepatitis.

Chronic liver cirrhosis (LC) and acute-on-chronic liver failure (ACLF) are interconnected hepatic disorders associated with substantial morbidity and ...

With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...

Researchers from the Roger Williams Institute of Liver Studies at King's College London developed two 3D models from human ...

Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...

Wegovy is now approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.

Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.

Liver checks are being offered at supermarkets and football matches and in offices as part of efforts to catch cancer early.

The approval makes Wegovy the only GLP-1 therapy cleared to treat adults with metabolic dysfunction-associated ...

Nat Clin Pract Gastroenterol Hepatol. 2007;4(5):236-237. Now that the idea that hepatic fibrosis is reversible is taking root, many clinicians are beginning to ask why, if fibrosis is reversible ...

The liver is the largest gland in the body, located in the upper right abdomen, primarily under the rib cage. It plays a ...